Home > Pharmacy > Other > Volume-8 > Issue-1 > Personalized eProtocol Design: A Data-Driven Approach with AI

Personalized eProtocol Design: A Data-Driven Approach with AI

Call for Papers

Volume-10 | Advances in Computer Applications and Information Technology

Last date : 25-Feb-2026

Best International Journal
Open Access | Peer Reviewed | Best International Journal | Indexing & IF | 24*7 Support | Dedicated Qualified Team | Rapid Publication Process | International Editor, Reviewer Board | Attractive User Interface with Easy Navigation

Journal Type : Open Access

First Update : Within 7 Days after submittion

Submit Paper Online

For Author

Research Area


Personalized eProtocol Design: A Data-Driven Approach with AI


Dr. A. V. Padmaja | Anusha Vemulapally | Jampula Srikanth



Dr. A. V. Padmaja | Anusha Vemulapally | Jampula Srikanth "Personalized eProtocol Design: A Data-Driven Approach with AI" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1, February 2024, pp.555-558, URL: https://www.ijtsrd.com/papers/ijtsrd63456.pdf

This review explores the transformative potential of Artificial Intelligence (AI) in reshaping clinical trial methodologies, focusing on cardiovascular and oncological applications. Drawing insights from oncology, the article by C K, KW J, WW T (2019) delves into how AI could redefine clinical trials in cardiovascular medicine. Shifting the paradigm towards personalized medicine, the study highlights lessons learned and prospects for AI integration in cardiovascular research. The article by H, P S, A B, J H (2019) examines the role of AI in clinical trial design, emphasizing trends in pharmacological sciences. The review underscores the evolving landscape of AI applications, emphasizing its impact on optimizing trial design processes. Delso et al. (2021) present a comprehensive guide on designing AI-driven clinical trials in Nuclear Medicine. The article addresses key considerations for implementing AI in this specialized field, offering insights into future directions and challenges.

Artificial Intelligence, Clinical Trials, Cardiovascular Medicine, Oncology, Pharmacological Sciences, Nuclear Medicine, Personalized Medicine, Trial Design Optimization, Lessons Learned, Trends, Challenges


IJTSRD63456
Volume-8 | Issue-1, February 2024
555-558
IJTSRD | www.ijtsrd.com | E-ISSN 2456-6470
Copyright © 2019 by author(s) and International Journal of Trend in Scientific Research and Development Journal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0)

International Journal of Trend in Scientific Research and Development - IJTSRD having online ISSN 2456-6470. IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas like Sciences, Technology, Innovation, Engineering, Agriculture, Management and many more and it is recommended by all Universities, review articles and short communications in all subjects. IJTSRD running an International Journal who are proving quality publication of peer reviewed and refereed international journals from diverse fields that emphasizes new research, development and their applications. IJTSRD provides an online access to exchange your research work, technical notes & surveying results among professionals throughout the world in e-journals. IJTSRD is a fastest growing and dynamic professional organization. The aim of this organization is to provide access not only to world class research resources, but through its professionals aim to bring in a significant transformation in the real of open access journals and online publishing.

Thomson Reuters
Google Scholer
Academia.edu

ResearchBib
Scribd.com
archive

PdfSR
issuu
Slideshare

WorldJournalAlerts
Twitter
Linkedin